Your browser doesn't support javascript.
loading
Penetration of new antidiabetic medications in East Asian countries and the United States: A cross-national comparative study.
Kubota, Kiyoshi; Kamijima, Yukari; Kao Yang, Yea-Huei; Kimura, Shinya; Chia-Cheng Lai, Edward; Man, Kenneth K C; Ryan, Patrick; Schuemie, Martijn; Stang, Paul; Su, Chien-Chou; Wong, Ian C K; Zhang, Yinghong; Setoguchi, Soko.
Affiliation
  • Kubota K; NPO Drug Safety Research Unit Japan, Tokyo, Japan.
  • Kamijima Y; NPO Drug Safety Research Unit Japan, Tokyo, Japan.
  • Kao Yang YH; Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
  • Kimura S; Japan Medical Data Center, Tokyo, Japan.
  • Chia-Cheng Lai E; Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina, United States of America.
  • Man KKC; Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, University of Hong Kong, Hong Kong, China.
  • Ryan P; Research Department of Practice and Policy, UCL School of Pharmacy, London, United Kingdom.
  • Schuemie M; Janssen Research & Development, LLC, Titusville, New Jersey, United States of America.
  • Stang P; Janssen Research & Development, LLC, Titusville, New Jersey, United States of America.
  • Su CC; Janssen Research & Development, LLC, Titusville, New Jersey, United States of America.
  • Wong ICK; Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
  • Zhang Y; Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, University of Hong Kong, Hong Kong, China.
  • Setoguchi S; Research Department of Practice and Policy, UCL School of Pharmacy, London, United Kingdom.
PLoS One ; 13(12): e0208796, 2018.
Article in En | MEDLINE | ID: mdl-30540837
ABSTRACT

BACKGROUND:

The number of patients with diabetes is increasing particularly in Asia-Pacific region. Many of them are treated with antidiabetics. As the basis of the studies on the benefit and harm of antidiabetic drugs in the region, the information on patterns of market penetration of new classes of antidiabetic medications is important in providing context for subsequent research and analyzing and interpreting results.

METHODS:

We compared penetration patterns of dipeptidyl peptidase-4 (DPP-4) inhibitors in Taiwan, Hong Kong, Japan, and the United States. We used the Taiwan National Health Insurance Research Database, a random sample of the Hong Kong Clinical Data Analysis and Reporting System, the Japan Medical Data Center database, and a 5% random sample of the US Medicare database converted to the Observational Medical Outcomes Partnership's Common Data Model to identify new users of oral antidiabetic medications. We standardized prevalence and incidence rates of medication use by age and sex to those in the 2010 Taiwanese population. We compared age, sex, comorbid conditions, and concurrent medications between new users of DPP-4 inhibitors and biguanides.

RESULTS:

Use of DPP-4 inhibitors 1 year after market entry was highest in Japan and lowest in Hong Kong. New users had more heart failure, hyperlipidemia, and renal failure than biguanide users in Taiwan, Hong Kong, and the United States while the proportions were similar in Japan. In a country with low penetration of DPP-4 inhibitors (eg, Hong Kong), users had diabetes with multiple comorbid conditions compared with biguanidine users. In a country with high penetration (eg, Japan), the proportion of users with comorbid conditions was similar to that of biguanide users.

CONCLUSIONS:

We observed a marked difference of the penetration patterns of newly marketed antidiabetics in different countries in Asia. Those results will provide the basic information useful in the future studies.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus / Dipeptidyl-Peptidase IV Inhibitors / Hypoglycemic Agents Type of study: Clinical_trials / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Aged80 / Child / Child, preschool / Female / Humans / Infant / Male Country/Region as subject: America do norte / Asia Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2018 Document type: Article Affiliation country: Japan

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus / Dipeptidyl-Peptidase IV Inhibitors / Hypoglycemic Agents Type of study: Clinical_trials / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Aged80 / Child / Child, preschool / Female / Humans / Infant / Male Country/Region as subject: America do norte / Asia Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2018 Document type: Article Affiliation country: Japan